(3RB.DE) Stock Price & Overview

FRA:3RBGB00B24CGK77

Current stock price

70.3 EUR
+1.1 (+1.59%)
Last:

The current stock price of 3RB.DE is 70.3 EUR. Today 3RB.DE is up by 1.59%. In the past month the price increased by 2.63%. In the past year, price increased by 10.71%.

3RB.DE Key Statistics

52-Week Range53.54 - 72.04
Current 3RB.DE stock price positioned within its 52-week range.
1-Month Range66.18 - 72.04
Current 3RB.DE stock price positioned within its 1-month range.
Market Cap
47.31B
P/E
16.46
Fwd P/E
16.49
EPS (TTM)
4.27
Dividend Yield
3.21%

3RB.DE Stock Performance

Today
+1.59%
1 Week
+1.53%
1 Month
+2.63%
3 Months
+6.23%
Longer-term
6 Months +9.81%
1 Year +10.71%
2 Years +5.15%
3 Years +6.19%
5 Years -0.99%
10 Years -14.89%

3RB.DE Stock Chart

 / 3RB Daily stock chart

3RB.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to 3RB.DE. When comparing the yearly performance of all stocks, 3RB.DE turns out to be only a medium performer in the overall market: it outperformed 62% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

3RB.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to 3RB.DE. While 3RB.DE is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

3RB.DE Earnings

On October 22, 2025 3RB.DE reported an EPS of 1.75 and a revenue of 6.98B. The company beat EPS expectations (0.74% surprise) and missed revenue expectations (-3.42% surprise).

Next Earnings DateMar 5, 2026
Last Earnings DateOct 22, 2025
PeriodQ2 / 2025
EPS Reported£1.75
Revenue Reported6.981B
EPS Surprise 0.74%
Revenue Surprise -3.42%

3RB.DE Forecast & Estimates

27 analysts have analysed 3RB.DE and the average price target is 79.31 EUR. This implies a price increase of 12.82% is expected in the next year compared to the current price of 70.3.

For the next year, analysts expect an EPS growth of 1.33% and a revenue growth 0.05% for 3RB.DE


Analysts
Analysts77.04
Price Target79.31 (12.82%)
EPS Next Y1.33%
Revenue Next Year0.05%

3RB.DE Groups

Sector & Classification

Index Membership

3RB.DE Financial Highlights

Over the last trailing twelve months 3RB.DE reported a non-GAAP Earnings per Share(EPS) of 4.27. The EPS increased by 19% compared to the year before.


Income Statements
Revenue(TTM)13.98B
Net Income(TTM)1.24B
Industry RankSector Rank
PM (TTM) 8.88%
ROA 5.05%
ROE 19.68%
Debt/Equity 1.26
Chartmill High Growth Momentum
EPS Q2Q%8.75%
Sales Q2Q%-2.6%
EPS 1Y (TTM)19%
Revenue 1Y (TTM)-2.41%

3RB.DE Ownership

Ownership
Inst Owners71.33%
Shares672.97M
Float672.67M
Ins Owners0.03%
Short Float %N/A
Short RatioN/A

About 3RB.DE

Company Profile

3RB logo image Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. The company is headquartered in Slough, Berkshire and currently employs 37,900 full-time employees. The company went IPO on 2007-10-23. The firm's operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.

Company Info

IPO: 2007-10-23

103-105 Bath Road

SLOUGH BERKSHIRE GB

Employees: 37900

3RB Company Website

3RB Investor Relations

Phone: 441753217800

/ 3RB.DE FAQ

What does do?

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. The company is headquartered in Slough, Berkshire and currently employs 37,900 full-time employees. The company went IPO on 2007-10-23. The firm's operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.


What is the current price of 3RB stock?

The current stock price of 3RB.DE is 70.3 EUR. The price increased by 1.59% in the last trading session.


Does pay dividends?

(3RB.DE) has a dividend yield of 3.21%. The yearly dividend amount is currently 2.27.


What is the ChartMill technical and fundamental rating of 3RB stock?

3RB.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


When does (3RB.DE) report earnings?

(3RB.DE) will report earnings on 2026-03-05, after the market close.


What is the ownership structure of (3RB.DE)?

You can find the ownership structure of (3RB.DE) on the Ownership tab.